
Rockwell Medical RMTI
$ 1.75
-2.78%
Quarterly report 2024-Q3
added 11-12-2024
Country |
![]() |
IPO year |
1998 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Russell H. Ellison M.Sc., M.D., MSc. |
Employees in the company |
299 |
Shares |
23.3 M |
Market Cap[1] |
$ 40.8 M |
EBITDA (LTM) |
$ 1.14 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.